|
|
| |
 Brief Description |
| |
| This presentation at the APSARD Symposium at Philadelphia 2009 discusses recent advances in clinical research focused on combined ADHD and Anxiety. Eli Lilly and Shire sponsored the filming, broadcast and archiving of the content of this symposium. MediCom offered continuing medical education with this content.
|
| |
Full Description |
| |
|
| |
Citation |
| |
|
| |
Abstract |
| |
|
| |
Introduction |
| |
|
| |
Results |
|
|
|
Discussions |
| |
|
| |
Material Methods |
| |
|
| |
References |
| |
| Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, Deldar A, Schuh K, Durell T. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety. 2009;26(3):212-21.
Geller D, Donnelly C, Lopez F, Rubin R, Newcorn J, Sutton V, Bakken R, Paczkowski M, Kelsey D, Sumner C. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2007 Sep;46(9):1119-27.
Friedlander AH, Yagiela JA, Mahler ME, Rubin R. The pathophysiology, medical management and dental implications of adult attention-deficit/hyperactivity disorder. J Am Dent Assoc. 2007 Apr;138(4):475-82 |
| |
|
|
|
Stats |
| |
| Publish date |
Views |
Ref# |
| Jan 05, 2010 |
955 |
VA:11:15:2136:2009 |
|
| |
Rating |
|
|
|
|
|
Embed Code
|
|
|
| |
Files |
| |
|
| |
| |
|
